期刊文献+

重庆地区192例HIV/HCV合并感染者的回顾性研究 被引量:5

Retrospective analysis of 192 cases of HIV/HCV co-infection in Chongqing
原文传递
导出
摘要 目的分析重庆地区艾滋病病毒(HIV)/丙型肝炎病毒(HCV)合并感染的发生率及危险因素;了解HIV合并慢性HCV感染者HCV-IgG抗体的产生情况,分析部分病人不能产生HCV-IgG的可能危险因素。方法回顾性收集HIV/HCV合并感染者资料,分析合并感染的可能危险因素;统计HIV合并慢性HCV感染者HCV-IgG阴性发生率,分析其HCV-IgG阴性的可能危险因素。结果 3 013例HIV感染者/艾滋病病人中合并HCV感染192例(6.37%);合并感染HCV者的HIV病毒载量[(4.97±0.89)log拷贝/mL]低于单纯HIV感染者[(5.15±0.81)log拷贝/mL](P〈0.05);合并感染者中吸毒人数的比例(64.06%)高于单纯HIV感染者(0.92%)(P〈0.05)。合并感染者中13例(6.77%)HCV-IgG阴性。单因素分析显示,HCV-IgG阴性组较阳性组年龄偏大(P〈0.05),HCV-IgG阴性组通过性途径导致感染所占比例(92.31%)高于阳性组(31.84%)(P〈0.05);多因素分析显示,通过性途径导致合并感染者出现HCV-IgG阴性的风险,为通过静脉吸毒途径导致感染者的52.669倍。结论重庆地区HIV/HCV合并感染发生率较高,静脉吸毒是合并感染的高危因素;合并HCV感染可能抑制HIV复制;年龄、传播途径为HIV/HCV合并感染者产生HCV-IgG的危险因素,其中性传播为影响HCV-IgG产生的独立危险因素。 Objective To analyze the incidence and risk factors of HIV/HCV co-infection in Chongqing and to understand the status of HCV-IgG antibodies in HIV-positive patients.Risk factors were analyzed esp.among the patients who could not produce HCV-IgG antibodies.Methods Retrospective analysis was made based on the collected clinical data of HIV/HCV co-infected patients followed by the analysis of risk factors,and HCV-IgG negative incidence of HIV/HCV co-infection.Results Among the 3013 HIV-infected patients,192(6.4%)were infected with HCV.HIV/HCV co-infected patient(4.97±0.89 log copy/mL)had significantly lower HIV-RNA levels than the pure HIV-infected patients(5.15±0.81 log copy/mL)(P〈0.05).The proportion of drug addicts in HIV/HCV co-infection(64.0%)was higher than that in HIV-infected patients(0.92%)(P〈0.05).There were 13 cases(6.8%)of HCV-IgG negative in the HIV/HCV co-infected patients.Single factor analysis showed that HCVIgG negative group was older than the positive group(P〈0.05),and the proportion of HCV-IgG negative group infected via sexual transmission(92.31%)was significantly higher than that of the positive group(31.84%).Multivariate analysis showed that the risk of HCV-IgG negative in the co-infected group via sexual transmission was52.669 times greater than that by intravenous drug use.Conclusion The incidence of HIV/HCV co-infection in Chongqing is 6.4%,and intravenous drug use is a high risk factor for HIV/HCV co-infection.HCV infection may inhibit the replication of HIV-RNA.Age and route of transmission are risk factors for HCV-IgG in HIV/HCV infected patients, and sexual transmission is an independent risk factor for HCV-IgG.
作者 刘敏 何小庆 罗亚东 袁婧 吴玉珊 谭顺 王静 陈耀凯 LIUMin;HE Xiaoqing;LUO Yadong;YUAN Jing;WU Yushan;TAN Shun;WANG Jing;CHEN Yaokai(Chongqing Public Health Medical Center,Chongqing 400036,China)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2018年第8期828-830,834,共4页 Chinese Journal of Aids & STD
基金 重庆市卫生计生委医学科研计划项目(2017MSXM119)~~
关键词 艾滋病病毒 丙型肝炎病毒 合并感染 丙型肝炎病毒IgG HIV Co-infection HCV HCV-IgG
  • 相关文献

参考文献4

二级参考文献30

  • 1Mehta SH, Cox A, Hoover DR, et al. Protection against persistence of hepatitis C [J]. Lancet, 2007,35 (9) : 1478- 1483.
  • 2Reiberger T, Ferlilsch A sieghart W, et al. HIVHW co-infected patients with low CD4^+ cell nadirs are at risk for faster fibrosis progression and portal hypertension[J]. Viral Hepat, 2009, 25:33-39.
  • 3Begovac J, Romih V. Treatment of chronic hepatitis C in human immunodeficiency virus infected patients. Aeta med Croation, 2009,63(5):423-429.
  • 4Wang TY, Kuo HT, Chen LC, et al. Use of polymerase chain reaction for early detection and meanagement of hepatitis C virus infection after needlestick injury[J]. Ann Clin Lab Sci, 2002,32(2):135 -137.
  • 5Verueehi G, Calza I, Manfredi R, et al. Human Immunodcficicncy virus and Hepatitis C Virus coinfection:Epidemiology, Naturai History, Therapeutic Ootions and clinical management[J]. Infection,2004,32(1):33-46.
  • 6Fukuda Y, Nakan I, Katano Y, et al. Assessment and treatment of liver disease in Japanese haemophilia patients[J]. Heamphilia, 1998,4(4):595- 600.
  • 7Puoti M, Bruno R, Soriano V, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome [J]. AIDS. 2004,18(17) :2285-2293.
  • 8Mohammadi M, Talei G, Sheikhian A, et al. Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients[J]. Virol J, 2009,6:202 206.
  • 9Sulkowski MS. Hepatitis C virus infection in HIV- infected patients[J]. Curr HIV/AIDS Rep, 2004,1 (3) :128-135.
  • 10Cao YZ, Fried-Kien AE, Huang YX, et al. CD4 in depent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro [J]. J Virol, 1990,64(6):2553-2559.

共引文献56

同被引文献58

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部